Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer, October 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 165 articles: HTML format

Single Articles

1. WU B, Liu Q
   Epidemiological characteristics of cervical cancer in Asian populations and risk factor inference based on Mendelian randomization.
   Medicine (Baltimore). 2026;105:e51015.
   PubMed    
   Abstract available
   
   

2. ALMALKI ZS, Alamer AA, Alhumaid SK, Alsuhibani AA, et al
   Cost-effectiveness of pembrolizumab plus chemoradiotherapy versus placebo plus chemoradiotherapy for high-risk locally advanced cervical cancer in Saudi Arabia: A model-based economic evaluation.
   Medicine (Baltimore). 2026;105:e50990.
   PubMed    
   Abstract available
   
   

3. KARIRI YA, Kuriry IA, Albargy HA, Keraryi FA, et al
   Sociodemographic correlates of human papilloma virus (HPV) and cervical cancer knowledge among Saudi women: A nationwide assessment.
   Medicine (Baltimore). 2026;105:e50955.
   PubMed    
   Abstract available
   
   

4. SETIYAWATI N, Sulistyowati S, Priyanto H
   Mapping community-based health promotion strategies for cervical cancer screening uptake: A scoping review of intervention components, delivery models and implementation gaps.
   Public Health Pract (Oxf). 2026;12:100857.
   PubMed    
   Abstract available
   
   

5. ZHAO Q, Yang C, Bu Q, Sun X, et al
   From HPV genotypes to cervical lesion burden: public health-relevant heterogeneity across 1.29 million screening records in Guangdong, China.
   Front Public Health. 2026;14:1897790.
   PubMed    
   Abstract available
   
   

6. ZHAO W, Sun Y, Ramadhany MMA, Wu R, et al
   Squamous cell carcinoma arising from ovarian mature cystic teratoma with concurrent cervical high-risk HPV infection and low-grade squamous intraepithelial lesion: a case report.
   BMC Womens Health. 2026;26:487.
   PubMed    
   Abstract available
   
   

7. BURRELL A
   Yonder: Livestreaming clinical education, complaints, weather and mental health, and HPV and cervical cancer screening.
   Br J Gen Pract. 2026;76:463.
   PubMed    
   
   
   

8. PRASARTSEREE T, Dankulchai P, Sittiwong W, Laolugsanalerd P, et al
   Hypofractionated 44 Gy in 20 fractions versus conventional chemoradiation in cervical cancer: 2-year results of the randomized HYPOCx-iRex trial with an exploratory pooled analysis of a single-institute EMBRACE-II cohort.
   Brachytherapy. 2026 Oct 1:S1538-4721(26)00306.
   PubMed    
   Abstract available
   
   

9. DE PAEPE E, Bertucci S, Ssetaala A, Amenu D, et al
   Transitioning to HPV-based cervical cancer screening in four low- and middle-income countries: policy and implementation pathways from a scoping review.
   J Cancer Policy. 2026 Oct 1:100812. doi: 10.1016/j.jcpo.2026.100812.
   PubMed    
   Abstract available
   
   

10. 
    Statement of retraction: Transcriptional factor 3 binds to sirtuin 1 to activate the Wnt/beta-catenin signaling in cervical cancer.
    Bioengineered. 2026;17:2731276.
    PubMed    
    
    
    

11. A-PHAILUN N, Kadman B, Chanlaor S, Takemura A, et al
    Interfractional variability and reproducibility of accumulated dose in cervical cancer radiotherapy associated with bladder volume.
    Radiol Phys Technol. 2026 Oct 1. doi: 10.1007/s12194-026-01138.
    PubMed    
    Abstract available
    
    

12. MARTINEZ O, Cora-Cruz M, Perez S, French A, et al
    The development of juntas contra el virus del papiloma humano: An HPV self-sampling intervention for underscreened Latinas.
    Womens Health (Lond). 2026;22:17455057261493721.
    PubMed    
    Abstract available
    
    

13. JAVED M, Jagannath D, Mathew A, Harms K, et al
    Gaps in cervical cancer screening and HPV vaccination in women with systemic lupus erythematosus.
    Lupus. 2026 Oct 1:9612033261494026. doi: 10.1177/09612033261494026.
    PubMed    
    
    
    

14. TAOUAF J, Loukid M, Lamtali S
    Factors influencing compliance with cervical cancer screening guidelines among women aged 30 to 49 years in Morocco.
    Afr J Reprod Health. 2026;30.
    PubMed    
    Abstract available
    
    

15. ALSHEHRI E, AlHakeem M, Almahmoud RA, AlKulyah AA, et al
    Cervical cancer prevention in Riyadh: a cross-sectional analysis of sociodemographic correlates, knowledge-awareness-practice gaps, and healthcare provider influence.
    Front Oncol. 2026;16:1890017.
    PubMed    
    Abstract available
    
    

16. GU X, Xu M, Dai J, Li X, et al
    Case Report: PRaG 3.0 therapy for advanced cervical cancer with severe comorbidities.
    Front Oncol. 2026;16:1912098.
    PubMed    
    Abstract available
    
    

17. PINTO CLDG, Crespo-Albiac L, Hunter TM, Lin P, et al
    Cervical cancer screening among US women with pelvic organ prolapse.
    Res Sq [Preprint]. 2026 Sep 11:rs.3.rs-10537590.
    PubMed    
    Abstract available
    
    

18. QIAN C, Cai X, Shi L, Li A, et al
    Exosomal miR-143-3p released from cancer cells suppresses cervical cancer progression and promotes ferroptosis through directly targeting KLF5.
    Histol Histopathol. 2026 Oct 1:25146. doi: 10.14670.
    PubMed    
    Abstract available
    
    

19. NEDUNCHEZHIAN S, Palaniyandi T, Surendran H, Baskar G, et al
    Strategies for Cervical Cancer Treatment using the Regenerative Potentials of Mesenchymal Stem Cells.
    Curr Pharm Des. 2026 Sep 29. doi: 10.2174/0113816128501994260915105716.
    PubMed    
    Abstract available
    
    

20. EFE CAMILI F, Aksu S
    HPV knowledge, awareness, and vaccine beliefs among women attending gynecological care in Turkiye: implications for cervical cancer prevention.
    Infect Agent Cancer. 2026;21:63.
    PubMed    
    Abstract available
    
    

21. FENG C, Wang J, Zhang Y, Feng Y, et al
    Tumor cell membrane?coated MOF?199 nanoparticles co?loaded with auranofin and celecoxib enhance single?dose radiotherapy and anti?PD?L1 therapy in cervical cancer.
    J Nanobiotechnology. 2026;24:916.
    PubMed    
    Abstract available
    
    

22. GILHAM C
    Socioeconomic inequalities in cervical cancer screening coverage in England.
    J Med Screen. 2026 Sep 30:9691413261484526. doi: 10.1177/09691413261484526.
    PubMed    
    Abstract available
    
    

23. WANG J, Zhao J, Liu R, Qi X, et al
    Alkaline Phosphatase-Responsive Composite Hydrogels Modulating Tumor Mechanical Properties for Cervical Cancer Therapy.
    ACS Appl Mater Interfaces. 2026 Sep 30. doi: 10.1021/acsami.6c14164.
    PubMed    
    Abstract available
    
    

24. MECKLAI K, Mehta N, Oh C, Jabban S, et al
    Disparities in sexual health counseling and treatment among patients undergoing chemoradiation for the treatment of cervical cancer.
    J Sex Med. 2026;23:qdag304.
    PubMed    
    
    
    

25. LI D, Wen M, Zhao Y, Nie T, et al
    Prevalence and Factors Associated With Financial Toxicity in Cervical Cancer Patients: A Cross-Sectional Study.
    Nurs Open. 2026;13:e70873.
    PubMed    
    Abstract available
    
    

26. YACOB SM, Malik RA
    Outcomes and patterns of management of metastatic/recurrent cervical carcinoma in Malaysia: A single institutional observational cohort study.
    Med J Malaysia. 2026;81:669-676.
    PubMed    
    Abstract available
    
    

27. PEACOCK AM, Brown KGM, Lee PJM, Austin KKS, et al
    Pelvic Exenteration for Cervical Cancer: Oncological, Morbidity and Quality of Life Outcomes.
    J Surg Oncol. 2026 Sep 30. doi: 10.1002/jso.70396.
    PubMed    
    Abstract available
    
    

28. LIU J, Liu Y, Jiang Y, Wang X, et al
    Declining trends but persistent disparities in cervical cancer mortality in the United States, 1999-2023.
    Front Public Health. 2026;14:1892243.
    PubMed    
    Abstract available
    
    

29. WANG SP, Chen ZG, Shan XJ, Jin M, et al
    Development and validation of a multimodal MRI habitat-based deep learning fusion model for predicting (252)Cf neutron therapy response in cervical cancer.
    World J Radiol. 2026;18:123597.
    PubMed    
    Abstract available
    
    

30. SRIRAM S
    Vaccinating girls, abandoning women: the financing asymmetry between HPV immunization and the cervical cancer treatment cascade in low- and middle-income countries.
    Front Oncol. 2026;16:1941545.
    PubMed    
    Abstract available
    
    

31. MA Y, Liu Y, Gao N, Huo Y, et al
    [Multiple components in Astragalus Injection target CCL2/FOS/PPARG/CXCL8 to suppress cervical cancer progression].
    Nan Fang Yi Ke Da Xue Xue Bao. 2026;46:2206-2221.
    PubMed    
    Abstract available
    
    

32. SARKER RR, Ferdous J, Yeasmin S, Rahman S, et al
    Association between Serum Folate Status and Cervical Intraepithelial Neoplasia.
    Mymensingh Med J. 2026;35:1225-1233.
    PubMed    
    Abstract available
    
    

33. SHOARISHOAR SS, Seifollahi Marbini M
    Human Papillomavirus (HPV) and Cervical Cancer: An Exploratory Systematic Review of Heterogeneous Evidence on Epidemiology, Vaccination, Screening, and Molecular Advances.
    Cancer Invest. 2026 Sep 29:1-19. doi: 10.1080/07357907.2026.2740708.
    PubMed    
    Abstract available
    
    

34. WANG M, Brand A, Plymoth M, Chen J, et al
    Implementation of self-collected cervical screening in an under-screened, culturally and linguistically diverse antenatal population: a quality improvement study.
    BMJ Open Qual. 2026;15:e004525.
    PubMed    
    Abstract available
    
    

35. LU W, Wang W, Sun L, Sun H, et al
    STAT5A-RNF8 signaling regulates homologous recombination repair and cisplatin responsiveness in cervical cancer.
    Neoplasia. 2026;81:101372.
    PubMed    
    Abstract available
    
    

36. JIN S, Gao D, Xiahou Y, Tao J, et al
    STC2 promotes cisplatin resistance through metabolic reprogramming and lactylation-mediated epigenetic regulation in cervical cancer.
    Acta Biochim Biophys Sin (Shanghai). 2026 Sep 29. doi: 10.3724/abbs.2026169.
    PubMed    
    Abstract available
    
    

37. LIM MSH, Tan SSN, Bujang MA, Shandra JFA, et al
    A Cross-Sectional Study of Knowledge, Attitudes, and Perceptions toward HPV Vaccination Among Undergraduate Students Studying in Sarawak, Malaysia.
    Asian Pac J Cancer Prev. 2026;27:3365-3375.
    PubMed    
    Abstract available
    
    

38. SERIKOVA-ESENGELDINA D, Issenova B, Siyazbekova Z, Samarova U, et al
    Global Trends and Disparities in Cervical Cancer Control in Central Asia (1990-2023): A Comparative Age-Period-Cohort and Joinpoint Regression Analysis.
    Asian Pac J Cancer Prev. 2026;27:3307-3313.
    PubMed    
    Abstract available
    
    

39. SANTOS ABC, Carobeli LR, Meirelles LEF, De Souza MVF, et al
    Emerging Insights into Comparative Genetic Mutations in HPV-Associated and HPV-Independent Cervical Cancer: A Systematic Review.
    Asian Pac J Cancer Prev. 2026;27:3139-3150.
    PubMed    
    Abstract available
    
    

40. HUANG L, Wan Y, Yang Z, Zhou Z, et al
    HIV-associated immune remodeling in cervical cancer: implications for immunotherapy, biomarkers, and trial design.
    Front Immunol. 2026;17:1953030.
    PubMed    
    Abstract available
    
    

41. LI Y, Li R, Duan R, Gu X, et al
    Assessment of Factors and Trends Affecting Different Pathological Types of Cervical Cancer in China From 2013 to 2022.
    Cancer Med. 2026;15:e72259.
    PubMed    
    Abstract available
    
    

42. MIYAKE T, Sasa H, Ito T, Watanabe T, et al
    Metastasis of Invasive Ductal Carcinoma of the Breast to the Uterine Cervix 30 Years Post-Mastectomy: A Case Report.
    J Obstet Gynaecol Res. 2026;52:e70509.
    PubMed    
    Abstract available
    
    

43. NARASIMHAN RM, Wassel M, Herbach E, McNeilly S, et al
    FEBE: The female brachytherapy experience. Assessing PTSD symptom rates in women treated for locally advanced cervical cancer with HDR brachytherapy.
    Brachytherapy. 2026 Sep 28:S1538-4721(26)00281.
    PubMed    
    Abstract available
    
    

44. UEDA Y, Tsuji M, Mori M, Kusanagi A, et al
    Modulation of intracellular heme metabolism enhances artesunate-induced cytotoxicity in CD44v-positive cervical cancer cells.
    Free Radic Biol Med. 2026;257:66-76.
    PubMed    
    Abstract available
    
    

45. KOU K, Yamanoi K, Kobara H, Komatsu H, et al
    Clinical significance of MRI-based tumor status differs by histological subtype in early-stage cervical cancer.
    Eur J Radiol. 2026;205:113271.
    PubMed    
    Abstract available
    
    

46. TAWFEEK HM, A H Abddelatif A, Barakat H
    Spotlights on Cervical Cancer: Progression, Diagnosis and Clinical Manifestations, Epidemiology, Treatment Approaches, Role of Artificial Intelligence and Future Directions.
    Drug Dev Ind Pharm. 2026 Sep 28:1-28. doi: 10.1080/03639045.2026.2741083.
    PubMed    
    Abstract available
    
    

47. MACHANGE RF, Njau B, Mtuya CC, Katiti VW, et al
    Perspectives of women and healthcare providers on facilitators and barriers to cervical cancer screening in the rural Kilimanjaro region Tanzania: a qualitative study.
    Glob Health Action. 2026;19:2735552.
    PubMed    
    Abstract available
    
    

48. ZHOU X, Yao D, Li T, Guo Z, et al
    Knowledge and attitudes of medical students about human papillomavirus (HPV) and HPV vaccine: A cross-sectional survey in Inner Mongolia, China.
    Hum Vaccin Immunother. 2026;22:2738975.
    PubMed    
    Abstract available
    
    

49. AHMADI SH, Mohammadi SS, Koozari A, Elhaie M, et al
    Deep Learning and Machine Learning Algorithms for Cervical Cancer Segmentation on MRI: A Systematic Review.
    J Med Radiat Sci. 2026 Sep 27:10.1002/jmrs.70127. doi: 10.1002/jmrs.70127.
    PubMed    
    Abstract available
    
    

50. CHEN R, Yuan Y, Zhang Z, Yang N, et al
    [Inhibition of RBM5 expression by the interaction between hsa_circ_0006200 and EIF4A3 and its impact on cervical cancer progression].
    Zhonghua Fu Chan Ke Za Zhi. 2026;61:748-759.
    PubMed    
    Abstract available
    
    

51. LING Y, Wu MX, You ZX
    [Clinical observational study on detection and treatment of adenocarcinoma in situ of the cervix].
    Zhonghua Fu Chan Ke Za Zhi. 2026;61:739-747.
    PubMed    
    Abstract available
    
    

52. WANG Q, Xiao Y, Chao JZ, Ma ZL, et al
    [Analysis of risk factors for pathological upgrading after cervical conization in patients with CIN1].
    Zhonghua Fu Chan Ke Za Zhi. 2026;61:733-738.
    PubMed    
    Abstract available
    
    

53. ANTORA HK, Mosaddeque MB, Mim NN, Tasnim J, et al
    Diagnostic utility of HPV-16/18 E6 mRNA fold change measured by in-house semi-quantitative real-time PCR in cervical cancer triage for differentiation of CIN3 and cervical cancer from lower-grade lesions.
    Diagn Microbiol Infect Dis. 2026;117:117668.
    PubMed    
    Abstract available
    
    

54. ZHANG L, Zhao F, Zhang L, Jia K, et al
    GNAS-AS1 Promotes M2-Like Macrophage Polarization, Contributing to Cervical Cancer Growth, Angiogenesis, and Metastasis Through the miR-518c-5p/FBXO38 Axis and MAPK Signaling.
    Mol Carcinog. 2026 Sep 27. doi: 10.1002/mc.70110.
    PubMed    
    Abstract available
    
    

55. ON S
    Comment of 'Subsequent primary cancer incidence in cervical cancer survivors: insights from a comprehensive cohort study utilizing combined Japanese population-based cancer registries'.
    J Gynecol Oncol. 2026 Sep 16. doi: 10.3802/jgo.2026.
    PubMed    
    
    
    

56. AMPOFO AG, Mackenzie LJ, Khumalo P, Chittem M, et al
    Senior High School Nurse-led Education (SHiNE) for improving cervical cancer primary prevention among students in Ghana: Pilot cluster non-randomized controlled trial.
    Public Health. 2026;260:106495.
    PubMed    
    Abstract available
    
    

57. JING S, Dai Z, Yang X, Xin Y, et al
    The Effectiveness of a 6-Week Online Mindfulness-Based Intervention on Patients With Cervical Cancer or High-Grade Squamous Intraepithelial Lesion: A Randomized Controlled Trial Using Multimodal Data of Scales and Electroencephalogram.
    Psychooncology. 2026;35:e70610.
    PubMed    
    Abstract available
    
    

58. PAN YX, Chen WF, Li R, Zhang MJ, et al
    Prognostic impact of HLA-G expression in cervical squamous cell carcinoma: correlation with PD-L1 and CD8-positive tumor infiltrating lymphocytes.
    Front Immunol. 2026;17:1957106.
    PubMed    
    Abstract available
    
    

59. AN X, Jiao M, Dong ZW, Teng F, et al
    Ovarian dose prediction after ovarian transposition in cervical cancer: comparing three models and the impact of geometric distance on predictive performance.
    Front Oncol. 2026;16:1906826.
    PubMed    
    Abstract available
    
    

60. LI H, Zhao H, Liang L, Chen M, et al
    Clinical significance of Chlamydia trachomatis and HPV coinfection across cervical lesion severity: a 10-year retrospective study in Southern China.
    Front Cell Infect Microbiol. 2026;16:1832343.
    PubMed    
    Abstract available
    
    

61. KANG Y, Wu Y, Bao B, Wang X, et al
    Base editing-mediated induction of stop codons in HPV18 E6/E7 for cervical cancer therapy.
    Mol Ther. 2026 Sep 25:S1525-0016(26)00805-1. doi: 10.1016/j.ymthe.2026.
    PubMed    
    Abstract available
    
    

62. ZHAO N, Zhang X, Luo J, Zhang X, et al
    Study on Echinacoside-Copper Metal-Phenolic Networks Hydrogel System Loaded with Diallyl Trisulfide for Local Treatment of Cervical Cancer.
    Pharmaceutics. 2026;18:1126.
    PubMed    
    Abstract available
    
    

63. CHEN Q, Yang H, Pei M, Sun Y, et al
    A Locally Injectable, pH/ROS-Responsive Hydrogel Platform for Combination Therapy of Cervical Cancer with Anti-Fibrotic and Chemotherapeutic Agents.
    Pharmaceutics. 2026;18:1115.
    PubMed    
    Abstract available
    
    

64. DOGAN O, Killi MC, Bakir MS, Yuksek S, et al
    Diagnosis of Rare Cervical Tumors: IECC Classification, HPV Status, and Subtype-Directed Immunohistochemistry, with Treatment Outcomes from a Tertiary Center.
    Pathogens. 2026;15:907.
    PubMed    
    Abstract available
    
    

65. KOURI MA, Kalkou ME, Platoni K, Kollaros N, et al
    Integrating Gold Nanoparticles with Brachytherapy: In Vitro Insights into Radiosensitization in Cervical Cancer.
    Cancers (Basel). 2026;18:3025.
    PubMed    
    Abstract available
    
    

66. TOTH R, Sebok P, Spanics C, Szerencses D, et al
    Beyond Access and Awareness: The Role of Patient Experience and Physician Communication in Cervical Cancer Screening Participation in Hungary.
    Cancers (Basel). 2026;18:2999.
    PubMed    
    Abstract available
    
    

67. YORDANOV A, Dimitrova VD
    Integrated Immune Escape in Cervical Cancer: HLA-I Dysfunction and Immune Checkpoint Signaling.
    Int J Mol Sci. 2026;27:8009.
    PubMed    
    Abstract available
    
    

68. SOZEN I, Turan Bakirci I, Ataseven E, Ustundag P, et al
    Routine Blood-Based Parameters Associated with Invasive Cervical Cancer Versus High-Grade Cervical Intraepithelial Neoplasia: Development of a Retrospective Diagnostic Prediction Model.
    Diagnostics (Basel). 2026;16:2884.
    PubMed    
    Abstract available
    
    

69. YORDANOV A, Yordanov T, Tsoneva E, Petrov I, et al
    Preventable, Yet Unprevented: The Cervical Cancer Screening Landscape in Eastern Europe and Bulgaria.
    Healthcare (Basel). 2026;14:2973.
    PubMed    
    Abstract available
    
    

70. YORDANOV A, Kostov S, Dimitrova PD, Hasan I, et al
    ROMO1 and CD47 in Cervical Cancer: Parallel but Independently Regulated.
    Curr Issues Mol Biol. 2026;48:862.
    PubMed    
    Abstract available
    
    

71. LUO X, Li J, Xing T, Liu S, et al
    Low-Dose Paclitaxel Combined with Dehydrocavidine Synergistically Suppresses Cervical Cancer by Inhibiting FASN/SCD1-Mediated Lipid Metabolism.
    Biomolecules. 2026;16:1354.
    PubMed    
    Abstract available
    
    

72. AYAG ME, Tuncer MC, Ozturk S
    Epigallocatechin Gallate Modulates the Cellular Response to Doxorubicin in HeLa Cervical Cancer Cells.
    Biomolecules. 2026;16:1299.
    PubMed    
    Abstract available
    
    

73. XU T, Ma M, Zhang J, Wang Y, et al
    FABP4/5-Mediated Lipid Reprogramming Is Associated with Immunosuppressive T Cell Crosstalk in Cervical Cancer After Chemoradiotherapy.
    Biomedicines. 2026;14:2072.
    PubMed    
    Abstract available
    
    

74. JIANG H, Yuan Z, Liu Z, Wang Y, et al
    A hybrid deep learning framework for automated treatment planning in cervical cancer radiotherapy.
    J Appl Clin Med Phys. 2026;27:e70806.
    PubMed    
    Abstract available
    
    

75. SULTANA F, De A, Bose S, Roychowdhury A, et al
    Clinical Evaluation of miR-135b-5p and miR-21-5p Expression on Self-Collected Cervical Swab Samples for Triaging HR-HPV-Positive High-Grade Preneoplastic Lesions in India.
    Genet Test Mol Biomarkers. 2026;30:264-275.
    PubMed    
    Abstract available
    
    

76. WIELAND U, Kreuter A
    [Vaccine prevention of HPV-associated diseases].
    Dermatologie (Heidelb). 2026;77:666-672.
    PubMed    
    Abstract available
    
    

77. DAI W, Liu Y, Du H, Guo C, et al
    Large-cohort screening projects in seven regions of China demonstrate the efficacy of extended HPV genotyping in triaging HPV-positive women.
    Int J Infect Dis. 2026;171:109077.
    PubMed    
    Abstract available
    
    

78. ALMESLAMANI AZ, Ahmad M, Nauman J, Ahmad LA, et al
    Human papillomavirus research in Gulf Cooperation Council (GCC) countries - current evidence, genotypes, and priority gaps: A scoping review.
    J Infect Public Health. 2026;19:103335.
    PubMed    
    Abstract available
    
    

79. WANG Y, Su Y, Zhang Y, Cai Y, et al
    Preoperative PET/CT phenotype of gastric-type endocervical adenocarcinoma: integrated morphological, metabolic, serological, and explainable machine-learning analysis.
    Eur J Nucl Med Mol Imaging. 2026;53:7204-7220.
    PubMed    
    Abstract available
    
    

80. XU Y, Du Y, Qin Z, Zheng A, et al
    Radical Hysterectomy for Non-Endometrioid Endometrial Cancer With Cervical Involvement: A Retrospective Cohort Study.
    J Surg Oncol. 2026;134:684-691.
    PubMed    
    Abstract available
    
    

81. HEINERT SW, Salas R, Ohman-Strickland P, Ikechi R, et al
    Acceptability of HPV self-sampling in three urban academic emergency departments.
    BMC Public Health. 2026;26:2715.
    PubMed    
    Abstract available
    
    

82. KASZA KA, Schneller-Najm LM, Sheffer CE, Haring RC, et al
    Cancer Screening Adherence in the United States by Smoking and Vaping Status, 2023.
    Cancer Prev Res (Phila). 2026;19:587-599.
    PubMed    
    Abstract available
    
    

83. HU X, Zhu M, Wang L, Yang K, et al
    HPV epidemiologic study in Bengbu, China, involving 123,808 women, 2014-2023.
    Virol J. 2026;23:227.
    PubMed    
    Abstract available
    
    

84. WILLEMART M, Bongrand C, Balaya V, Marcadet J, et al
    [Assessing and improving post-therapeutic surveillance of precancerous cervical lesions in Reunion Island].
    Gynecol Obstet Fertil Senol. 2026;54:475-479.
    PubMed    
    Abstract available
    
    

85. ARAI T
    Three Years of Bidirectional, Home-Based Opioid Route Management in Advanced Cervical Cancer with Coexisting Causes of Route Failure: A Case Report.
    J Pain Palliat Care Pharmacother. 2026.
    PubMed    
    Abstract available
    
    

86. MIRZAEV UK, Juraev JR, Sharipova IP, Islomov ST, et al
    Population?based registry analysis of cervical cancer trends in Tashkent Uzbekistan 2014-2024.
    JNCI Cancer Spectr. 2026 Oct 9:pkag107. doi: 10.1093.
    PubMed    
    Abstract available
    
    

87. KAZINDU TM, Lurhangire E, Mulume AB, Hermans MP, et al
    Cervical Cancer Knowledge, Attitudes, and Practices Among Informal Sector Women: Prevention Challenges in Eastern Democratic Republic of the Congo.
    Int J Womens Health. 2026;18:646534.
    PubMed    
    Abstract available
    
    

88. XIAO H, Wang F, Wang Y, Liu Y, et al
    Advances in the application of gene methylation detection in cervical cancer screening.
    Front Oncol. 2026;16:1920299.
    PubMed    
    Abstract available
    
    

89. SHERPA ML, Lucksom PG, Sherpa M, Pradhan A, et al
    Self-collected cervical samples for detection of high-risk human papillomavirus: A community outreach approach in a remote region.
    Indian J Med Res. 2026;164:559-565.
    PubMed    
    Abstract available
    
    

90. DEVOTTA K, Lofters A, Sayani A, Shapiro GK, et al
    Integrating behavioural science into HPV self-sampling and cervical cancer elimination strategies.
    Womens Health (Lond). 2026;22:17455057261484755.
    PubMed    
    Abstract available
    
    

91. SECK FB, Awadalla S, Diongue FB, Ndiaye I, et al
    Impact of cervical cancer-related stigma on screening uptake in Dakar and Kedougou, Senegal: A context-specific stigma index.
    PLOS Glob Public Health. 2026;6:e0006187.
    PubMed    
    Abstract available
    
    

92. YILDIZ P, Topcu G, Aydin G, Uzun A, et al
    Retrospective study of inflammatory markers in high-grade cervical lesions.
    Rev Assoc Med Bras (1992). 2026;72:e20260706.
    PubMed    
    Abstract available
    
    

93. SHEN H, Jiang Y, Sun Y, Zheng Q, et al
    Peritumoral ultrasound-driven multimodal AI model for predicting lymphovascular space invasion and prognosis in cervical cancer.
    Abdom Radiol (NY). 2026 Oct 8. doi: 10.1007/s00261-026-05804.
    PubMed    
    Abstract available
    
    

94. HERRERA ORTIZ AF, Del Castillo Herazo V, Olarte LM, Borrero Leon R, et al
    Advanced cervical cancer and its complications: a cross-sectional imaging review.
    Abdom Radiol (NY). 2026 Oct 8. doi: 10.1007/s00261-026-05809.
    PubMed    
    Abstract available
    
    

95. KUMAGAI K, Suzuki Y, Kitahara K, Chiba A, et al
    Host chromatin architecture in HPV-driven cervical cancer: molecular mechanisms and therapeutic resistance.
    Med Oncol. 2026;43:324.
    PubMed    
    Abstract available
    
    

96. ZHENG LF, Qian J, Song YF
    Prognostic Value of MiR-934 and MiR-1260a in Plasma and Early Detection of Metastasis in Patients with Cervical Cancer.
    Clin Lab. 2026;72:2065-2074.
    PubMed    
    Abstract available
    
    

97. JIN D, Dong Y
    Retrospective Analysis of HPV Infection Status and Genotyping in East China: 2023 - 2024.
    Clin Lab. 2026;72:2187-2193.
    PubMed    
    Abstract available
    
    

98. RAHMAN Z, Rice J, Edwards L, Sanad E, et al
    Respondent-Reported Acceptability and Tolerability of a Nurse-Assisted, Self-Collected Human Papillomavirus (HPV) Cervical Cancer Screening Model in Adults With Intellectual and Developmental Disabilities: A Preliminary Report.
    Cureus. 2026;18:e117558.
    PubMed    
    Abstract available
    
    

99. WU M, Shen L, Jiang N, Wang H, et al
    Perceived community cervical cancer prevention support and cervical cancer screening utilization among women in Shenzhen, China: a cross-sectional study.
    Front Public Health. 2026;14:1964812.
    PubMed    
    Abstract available
    
    

100. LI X, Xu S, Ren Y, Li M, et al
     Multimodality therapy for stage IB3 cervical cancer with a delayed diagnosis at 21 weeks of gestation: from neoadjuvant chemotherapy to adjuvant chemoradiotherapy-a case report.
     Front Med (Lausanne). 2026;13:1946977.
     PubMed    
     Abstract available
     
     

101. CAI R, Shen S, Gu C
     Cardio-oncology-relevant programmes in the cervical cancer tumour microenvironment: an exploratory multi-omics and endothelial-cell study.
     Front Cardiovasc Med. 2026;13:1917892.
     PubMed    
     Abstract available
     
     

102. 
     Correction to "HPV Infection Drives CXCL8(+) Neutrophil-Mediated Immune Suppression in Cervical Cancer".
     Biofactors. 2026;52:e70158.
     PubMed    
     
     
     

103. WANG F, Shan S, Huo Y, Xie Z, et al
     Corrigendum to "MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer" [Int. J. Biochem. Cell Biol. 99 (2018) 91-99].
     Int J Biochem Cell Biol. 2026 Oct 7:107038. doi: 10.1016/j.biocel.2026.107038.
     PubMed    
     
     
     

104. THE EDITORS OF THE LANCET GLOB
     Expression of concern-Effect of Brazil's national human papillomavirus vaccination programme on the incidence of cervical cancer and cervical intraepithelial neoplasia grade 3 in women aged 20-24 years: a population-based study.
     Lancet Glob Health. 2026 Oct 7:104113. doi: 10.1016/j.langlo.2026.104113.
     PubMed    
     
     
     

105. LU L, Wei X, Liu S, Lei S, et al
     RSPO1-LGR4 axis drives cervical cancer progression via activation of the EGFR/Src/ERK/AKT signaling pathway.
     Neoplasia. 2026;82:101374.
     PubMed    
     Abstract available
     
     

106. NAVYA VB, Fathima A, Kumar R
     Deciphering the role of microplastics-related molecular signatures in cervical cancer progression: Transcriptomic analysis and diagnostic model development.
     Biochem Biophys Res Commun. 2026;839:154678.
     PubMed    
     Abstract available
     
     

107. JENKINS WD, Choudhary V, Miller KW, Bhandari P, et al
     Urgent need for cervical cancer screening emphasis and engagement strategies among rural LGBTQ+ individuals.
     Prev Med Rep. 2026;71:103647.
     PubMed    
     Abstract available
     
     

108. WU J, Wang T, Sheng C, Wang W, et al
     Minimal residual disease in cervical cancer: biological persistence, ctHPV DNA-guided surveillance, and recurrence-directed intervention.
     Front Oncol. 2026;16:1938965.
     PubMed    
     Abstract available
     
     

109. SHEN HP, Lee MY, Chao WR, Chen AC, et al
     Immunohistochemical profiling of PD-L1 expression in neuroendocrine carcinoma of the uterine cervix.
     Front Immunol. 2026;17:1933853.
     PubMed    
     Abstract available
     
     

110. LIU L, Zhang Y, He L, Zhou L, et al
     Menstrual, reproductive, and contraceptive factors associated with cervical cancer in women aged
     Front Oncol. 2026;16:1931698.
     PubMed    
     Abstract available
     
     

111. RAIAH M
     [Is the cervical cancer screening program in Algeria effective using the Pap smear test?].
     Sante Publique. 2026;38:309-315.
     PubMed    
     Abstract available
     
     

112. PENNEY J, Chytyk-Praznik K
     Patient-Specific Dosimetric Impact of Online Adaptive Radiotherapy for Locally Advanced Cervical Cancer.
     Biomed Phys Eng Express. 2026 Oct 6. doi: 10.1088/2057-1976.
     PubMed    
     Abstract available
     
     

113. MOU J, Shashikumar S, Shah AK, Chaudhary A, et al
     Advances in isothermal nucleic acid amplification-based HPV assays for cervical cancer screening in low- and middle-income countries: A scoping review.
     Cancer Epidemiol. 2026;105:103244.
     PubMed    
     Abstract available
     
     

114. KOOHACHAISKUN N, Atjimakul T, Peeyananjarassri K, Klangsin S, et al
     Effects of Estriol-Lactobacilli Combination Versus Polycarbophil-Based Vaginal Moisturizer on Post-Radiation Vaginitis in Women With Cervical Cancer: A Randomized Controlled Trial.
     J Obstet Gynaecol Res. 2026;52:e70525.
     PubMed    
     Abstract available
     
     

115. DIONGUE FB, Ndiaye I, Sougou NM, Bassoum O, et al
     Health facility-related barriers associated with cervical cancer screenings in the health districts of Dakar and Kedougou (2023, Senegal).
     J Public Health Afr. 2026;17:1879.
     PubMed    
     Abstract available
     
     

116. ELLER K, Skerrett E, Huchko MJ, Kerner N, et al
     The Callascope: A portable, user-friendly, speculum-free device for diagnostic imaging of cervical cancer precursor lesions.
     NPJ Womens Health. 2026;4:32.
     PubMed    
     Abstract available
     
     

117. LEWIS G, Rabie T, Montes MA, Clegg A, et al
     Cost-effectiveness of self-sampling strategies for cervical cancer screening: a commentary.
     Br J Community Nurs. 2026;31:492-498.
     PubMed    
     Abstract available
     
     

118. HARPER DM, Lin PJ, Young AP, Rehkopf DH, et al
     College Attendance, Physical Disability, and Cervical Cancer Screening.
     JAMA Netw Open. 2026;9:e2637495.
     PubMed    
     
     
     

119. YADAV P, Alwani AA, Harries AD, Deshmukh PR, et al
     Leveraging sexually transmitted infection clinics for cervical cancer screening: evidence from India.
     Public Health Action. 2026;16:202-208.
     PubMed    
     Abstract available
     
     

120. KHAN A, Gullery K, Barber G, Ormandy J, et al
     Impact of Human Papillomavirus Primary Cervical Screening on Referral Rates and Outcomes for People Referred to Colposcopy for Clinical Reasons.
     Aust N Z J Obstet Gynaecol. 2026;66:e70184.
     PubMed    
     Abstract available
     
     

121. WANG P, Zhang M, Lai Y, Song T, et al
     Differential diagnostic value of PAX1 and JAM3 methylation for cervical intraepithelial neoplasia between premenopausal and postmenopausal women: a retrospective clinical study in China.
     Ann Med. 2026;58:2722566.
     PubMed    
     Abstract available
     
     

122. TSEGAYE AT, Kreimer AR, Shing JZ, Clarke MA, et al
     Hysterectomy-corrected incidence of cervical cancer among women with HIV in the United States, 2001-2019.
     J Natl Cancer Inst. 2026 Oct 3:djag352. doi: 10.1093.
     PubMed    
     Abstract available
     
     

123. DONG B, Wang Y, Qin Y, Chen L, et al
     Multi-omics profiling reveals homologous recombination repair hyperactivation as a therapeutic vulnerability in neuroendocrine cervical carcinoma.
     Signal Transduct Target Ther. 2026;11:424.
     PubMed    
     Abstract available
     
     

124. KAMASHIDZE K, Beruchashvili T, Nakashidze I, Ahmad S, et al
     BRIDGING THE COVERAGE-PARTICIPATION GAP: BEHAVIORAL DETERMINANTS OF CERVICAL CANCER SCREENING AMONG WOMEN IN ADJARA, GEORGIA.
     Georgian Med News. 2026;.
     PubMed    
     Abstract available
     
     

125. WANG Y, Yang H, Gu Q, Wang H, et al
     Repeated remimazolam sedation for interstitial brachytherapy in cervical cancer: a randomized controlled trial.
     Ann Med. 2026;58:2740294.
     PubMed    
     Abstract available
     
     

126. LI Y, Gu T, Ma L, Yao L, et al
     A pilot evaluation of ChatGPT-4o-assisted hypothesis generation for exploring potential links between fungal biology and cervical cancer.
     Antonie Van Leeuwenhoek. 2026;119:224.
     PubMed    
     Abstract available
     
     

127. TABASSUM Z, Hadi K, Sudheer A, Donakonda S, et al
     Bulk and single-cell transcriptomics identify tumor-specific epithelial PSAT1 as a ferroptosis-associated therapeutic target in cervical cancer.
     Comput Biol Chem. 2026;126.
     PubMed    
     Abstract available
     
     

128. ZHENG J, Su Z, Zhuo X, Chai H, et al
     Cervical cancer survival analysis by integrating multi-omics data through an adaptive weighted deep neural network.
     Comput Biol Chem. 2026;126.
     PubMed    
     Abstract available
     
     

129. ITO K, Nakajima Y, Ogawa H, Furusawa A, et al
     Long-term results of stereotactic body radiotherapy boost in patients with cervical cancer considered unsuitable for intracavitary brachytherapy.
     Jpn J Radiol. 2026 Oct 3. doi: 10.1007/s11604-026-02089.
     PubMed    
     Abstract available
     
     

130. BOUZIANE A, Essadi B, Bekhakh C, Bennani A, et al
     Colonic Angiosarcoma 16 Years After Pelvic Radiotherapy for Cervical Cancer: A Case Report.
     Cureus. 2026;18:e117323.
     PubMed    
     Abstract available
     
     

131. NEZE-SEBAKUNZI J, Doro Altan AM, Ceffa S, Guidotti G, et al
     Prevalence, high-risk HPV type profile, and factors associated with high-risk HPV infection among women living with HIV in Kinshasa, Democratic Republic of the Congo.
     Front Public Health. 2026;14:1914799.
     PubMed    
     Abstract available
     
     

132. BALASUBRAMANI L, Madhivanan P, Anand M, Gupta M, et al
     From evidence to implementation: a policy and health systems roadmap for cervical cancer elimination in India.
     Front Public Health. 2026;14:1906243.
     PubMed    
     Abstract available
     
     

133. HUANG L, Zeng W, Pan R, Yu Z, et al
     The construction of a predictive model for postoperative bladder paralysis in patients with cervical cancer based on logistic regression and nomogram.
     Front Oncol. 2026;16:1877348.
     PubMed    
     Abstract available
     
     

134. SINGH S, Srivastava M, Uppada P, Ameta D, et al
     The causal integration ladder: a multilevel evidence framework for therapeutic target evaluation in cervical cancer.
     Front Syst Biol. 2026;6:1874355.
     PubMed    
     Abstract available
     
     

135. HUBER L, Bootsma TI, Jean K, van Iersel CA, et al
     Awareness, barriers, experiences and preferences regarding cervical and breast cancer screening among transgender and non-binary individuals.
     Patient Educ Couns. 2026;153:109860.
     PubMed    
     Abstract available
     
     

136. TOLESSA A, Winer RL, Barsness CB, Desai J, et al
     Developing personas and empathy maps to understand perceptions of HPV self-sampling in the Somali American Community.
     Patient Educ Couns. 2026;153:109855.
     PubMed    
     Abstract available
     
     

137. CREAGH NS, Nightingale C, Brotherton JM, Hocking JS, et al
     The impact of the universal choice of self-collection on cervical screening participation in Australia's National Cervical Screening Program: A population-based interrupted time series analysis.
     Public Health. 2026;259:106474.
     PubMed    
     Abstract available
     
     

138. LU L, Xu C, Chen R, Lv W, et al
     A comparative study of treatment of persistent cervical low-grade squamous intraepithelial lesions with HPV16/18 infection.
     Photodiagnosis Photodyn Ther. 2026;61:105631.
     PubMed    
     Abstract available
     
     

139. OZUM G, Guraslan H, Tassolak H, Deniz L, et al
     Postoperative Outcomes of the Manchester-Fothergill Procedure: Cervical Cytology Adequacy and Transformation Zone Accessibility: A Prospective Cohort Study.
     Int Urogynecol J. 2026;37:3095-3104.
     PubMed    
     Abstract available
     
     

140. LIU X, Zhang T, Zou D, Zhang J, et al
     Efficacy and safety of 5-ALA-PDT in patients with persistent HR-HPV infection and lower genital tract low-grade intraepithelial lesions after cervical conization.
     Photodiagnosis Photodyn Ther. 2026;61:105576.
     PubMed    
     Abstract available
     
     

141. KONG D, Su Y, Gao C, Li L, et al
     The efficacy comparison of laser ablation combined with photodynamic therapy versus LEEP for women with CIN2/3 of childbearing age: a non-randomized case-control study.
     Photodiagnosis Photodyn Ther. 2026;61:105577.
     PubMed    
     Abstract available
     
     

142. OGBU CA, Okolie EA, Ume AO, Ajah OF, et al
     HPV knowledge and willingness to receive HPV vaccine among female secondary school students in Ebonyi State, Nigeria: a pre-post evaluation of an educational intervention.
     BMC Public Health. 2026;26:2878.
     PubMed    
     Abstract available
     
     

143. ROODSARABI M, Mirabi P, Farhadi Z, Delavar MA, et al
     The effect of using lubricant for vaginal speculum insertion on the rate of unsatisfactory results of Pap smear: a systematic review and meta-analysis.
     BMC Womens Health. 2026;26:508.
     PubMed    
     Abstract available
     
     

144. REN Y, Zhang X, Xu J
     Ectocervical margin involvement is associated with postoperative hrHPV positivity after hysterectomy or residual cervix resection for incompletely excised CIN3: a retrospective study.
     BMC Womens Health. 2026;26:504.
     PubMed    
     Abstract available
     
     

145. LI M, Zhang X, Zhao X, Wang J, et al
     Preliminary study on PAX1/JAM3 methylation and HPV viral load in CIN3-like squamous cell carcinoma: Are there differences from CIN3 and early invasive carcinoma?
     Clin Epigenetics. 2026;18:178.
     PubMed    
     Abstract available
     
     

146. PAN C, Hu S, You T, Gao M, et al
     Potential health impact of therapeutic HPV vaccines in China: a modeling study.
     BMC Med. 2026;24:539.
     PubMed    
     Abstract available
     
     

147. EVARIST MR, Kibonire RA
     Navigating the divide - demographic and individual predictors of low HPV vaccine uptake in rural Uganda.
     BMC Pediatr. 2026 Jul 3. doi: 10.1186/s12887-026-07143.
     PubMed    
     Abstract available
     
     

148. KONG D, Gao C, Li L, Chen R, et al
     The efficacy of laser ablation combined with photodynamic therapy vs PDT for CIN2/3 in reproductive women: a prospective case-control study.
     Photodiagnosis Photodyn Ther. 2026;61:105557.
     PubMed    
     Abstract available
     
     

149. OSHIRO CE, Cushing-Haugen KL, Vecchio NJD, Alonge OD, et al
     BMI and Initiation of Cancer Screening: A Closer Look at Differences by Race, Ethnicity, and Sex in a Multicenter Population.
     Am J Prev Med. 2026;71:108434.
     PubMed    
     Abstract available
     
     

150. PAUDICE M, Parrella V, Scaglione G
     Endocervical gastric-type AIS: a rare histologic finding that further supports the hypothesis of a pyloric-type metaplastic origin.
     Histopathology. 2026;89:892-894.
     PubMed    
     Abstract available
     
     

151. SRIDHAR S, Roukens MG, Yu CY, Dielen T, et al
     Molecular Profiling of Tisotumab Vedotin-Treated Patients Identifies Immune Pathways Associated with Clinical Activity.
     Clin Cancer Res. 2026;32:4365-4373.
     PubMed    
     Abstract available
     
     

152. ZULFIKAROGLU E
     Barriers to pelvic examination and cervical cancer screening in women with sexual trauma histories and sexual pain disorders: A systematic review and clinical practice synthesis.
     Int J Gynaecol Obstet. 2026 Sep 26. doi: 10.1002/ijgo.71375.
     PubMed    
     Abstract available
     
     

153. PAREJA R, Heredia F, Sanchez-Diaz E, Cuello MA, et al
     FIGO/IGCS statement on the efficacy of topical treatments for high-risk human papillomavirus in preventing CIN 3+ lesions.
     Int J Gynaecol Obstet. 2026;175:18-25.
     PubMed    
     Abstract available
     
     

154. LOPEZ-ALZA LC, Mejia-Perez DL, Amaya-Guio J, Orjuela-Canon AD, et al
     Predicting high-grade lesions and cervical cancer with supervised machine learning algorithms.
     Int J Gynecol Cancer. 2026 Sep 1:104997. doi: 10.1016/j.ijgc.2026.104997.
     PubMed    
     Abstract available
     
     

155. SHAFFI AF, Omwodo KA, Mburu A, Mutengo R, et al
     Financial toxicity as a structural barrier to cervical cancer treatment in Sub-Saharan Africa.
     Int J Gynecol Cancer. 2026;36:104902.
     PubMed    
     Abstract available
     
     

156. VIVEROS-CARRENO D, Mora-Soto N, Beshar I, Cruz C, et al
     Mapping country-level structural capacity constraints in brachytherapy infrastructure for locally advanced cervical cancer in the Americas: a cross-sectional study.
     Int J Gynecol Cancer. 2026;36:104863.
     PubMed    
     Abstract available
     
     

157. PEDRAO PG, Hirai WY, Losano GP, Pascoal GN, et al
     Relative diagnostic performance and feasibility of filter paper for storing self-collected vaginal samples for human papillomavirus testing in Brazil: A cross-sectional study.
     Int J Gynecol Cancer. 2026;36:104975.
     PubMed    
     Abstract available
     
     

158. NOLL F, Heredia F, Alvarenga-Bezerra V, Accioly Rosa A, et al
     Radiotherapy and brachytherapy capacity, treatment timelines, and barriers to guideline-concordant curative care for cervical cancer in Latin America: the LATAM-CxRT study.
     Int J Gynecol Cancer. 2026;36:104980.
     PubMed    
     Abstract available
     
     

159. POSSATI-RESENDE JC, de Araujo Batistao HK, Biot ST, Hirai WY, et al
     Cervical cancer prevention in motion: national impact of the Barretos Cancer Hospital model.
     Int J Gynecol Cancer. 2026;36:104968.
     PubMed    
     Abstract available
     
     

160. MORETTI-MARQUES R, Elizabeth de Moura V, Franca IB, Ernesto de Cillo P, et al
     Radical trachelectomy in Brazil: a multi-institutional review on fertility preservation and oncologic outcomes.
     Int J Gynecol Cancer. 2026;36:104978.
     PubMed    
     Abstract available
     
     

161. CUELLO MA, Pino MD, van den Brule AJC, Joura EA, et al
     Operationalizing cervical cancer elimination: a health-system archetype framework for implementation.
     Int J Gynecol Cancer. 2026;36:104966.
     PubMed    
     Abstract available
     
     

162. GUO H, Li H, Tian S, Zhang Y, et al
     Loperamide enhances the radiosensitivity of cervical cancer cells via ferroptosis induction.
     Oncol Rep. 2026;56:197.
     PubMed    
     Abstract available
     
     

163. PAN T, Zhuang X, Zhang Y, Guo J, et al
     Integrated multi-omics analysis reveals the molecular landscape and therapeutic strategies in Chinese cervical cancer patients.
     PLoS Biol. 2026;24:e3004029.
     PubMed    
     Abstract available
     
     

164. CHANG L, Kang Y, Zhu M, Liu J, et al
     Efficacy and safety of immune checkpoint inhibitors combined with TKIs for recurrent or metastatic cervical cancer with PIK3CA mutation.
     PLoS One. 2026;21:e0350571.
     PubMed    
     Abstract available
     
     

165. HENDRICKX M, Kerckhaert LA, Willems S, Crutzen R, et al
     Untimely follow-up after cervical cancer screening: A qualitative study among healthcare providers in Flanders (Belgium).
     PLoS One. 2026;21:e0359860.
     PubMed    
     Abstract available